BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25716933)

  • 1. A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma.
    Sjövall J; Wahlberg P; Almquist H; Kjellén E; Brun E
    Head Neck; 2016 Apr; 38 Suppl 1():E473-9. PubMed ID: 25716933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
    Sjövall J; Chua B; Pryor D; Burmeister E; Foote MC; Panizza B; Burmeister BH; Porceddu SV
    Oral Oncol; 2015 Mar; 51(3):260-6. PubMed ID: 25553622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy.
    Porceddu SV; Pryor DI; Burmeister E; Burmeister BH; Poulsen MG; Foote MC; Panizza B; Coman S; McFarlane D; Coman W
    Head Neck; 2011 Dec; 33(12):1675-82. PubMed ID: 22076976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
    Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
    Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
    Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
    Sjövall J; Brun E; Almquist H; Kjellén E; Wahlberg P
    Acta Otolaryngol; 2014 Jun; 134(6):646-51. PubMed ID: 24707930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
    Kao J; Vu HL; Genden EM; Mocherla B; Park EE; Packer S; Som PM; Kostakoglu L
    Cancer; 2009 Oct; 115(19):4586-94. PubMed ID: 19544537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
    Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
    Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
    Brkovich VS; Miller FR; Karnad AB; Hussey DH; McGuff HS; Otto RA
    Laryngoscope; 2006 Jun; 116(6):855-8. PubMed ID: 16735902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.
    Mortensen LS; Johansen J; Kallehauge J; Primdahl H; Busk M; Lassen P; Alsner J; Sørensen BS; Toustrup K; Jakobsen S; Petersen J; Petersen H; Theil J; Nordsmark M; Overgaard J
    Radiother Oncol; 2012 Oct; 105(1):14-20. PubMed ID: 23083497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
    Rogers JW; Greven KM; McGuirt WF; Keyes JW; Williams DW; Watson NE; Geisinger K; Cappellari JO
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):694-7. PubMed ID: 14967422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Wang YF; Liu RS; Chu PY; Chang FC; Tai SK; Tsai TL; Huang JL; Chang SY
    Head Neck; 2009 Apr; 31(4):442-51. PubMed ID: 19177422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron-emission tomography for surveillance of head and neck cancer.
    Ryan WR; Fee WE; Le QT; Pinto HA
    Laryngoscope; 2005 Apr; 115(4):645-50. PubMed ID: 15805874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from a standardized program using PET-CT to avoid neck dissection after primary radiotherapy for N2 squamous cell carcinoma of the oropharynx.
    Hitchcock KE; Amdur RJ; Mendenhall WM; Werning JW; Drane WE; Mancuso AA
    Oral Oncol; 2015 Sep; 51(9):870-4. PubMed ID: 26164415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
    Yao M; Graham MM; Hoffman HT; Smith RB; Funk GF; Graham SM; Dornfeld KJ; Skwarchuk M; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1001-10. PubMed ID: 15234033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer.
    Sjövall J; Bitzén U; Kjellén E; Nilsson P; Wahlberg P; Brun E
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):609-16. PubMed ID: 26428529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.